Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

por Van Acker, Heleen H, Anguille, Sébastien, Van Tendeloo, Viggo F, Lion, Eva
Publicado 2015

CD56 in the Immune System: More Than a Marker for Cytotoxicity?

por Van Acker, Heleen H., Capsomidis, Anna, Smits, Evelien L., Van Tendeloo, Viggo F.
Publicado 2017

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

por Van Acker, Heleen H., Anguille, Sébastien, De Reu, Hans, Berneman, Zwi N., Smits, Evelien L., Van Tendeloo, Viggo F.
Publicado 2018

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

por Van Acker, Heleen H., Anguille, Sébastien, Willemen, Yannick, Van den Bergh, Johan M., Berneman, Zwi N., Lion, Eva, Smits, Evelien L., Van Tendeloo, Viggo F.
Publicado 2016

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

por Anguille, Sébastien, Van Acker, Heleen H., Van den Bergh, Johan, Willemen, Yannick, Goossens, Herman, Van Tendeloo, Viggo F., Smits, Evelien L., Berneman, Zwi N., Lion, Eva
Publicado 2015

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

por Van Acker, Heleen H., Versteven, Maarten, Lichtenegger, Felix S., Roex, Gils, Campillo-Davo, Diana, Lion, Eva, Subklewe, Marion, Van Tendeloo, Viggo F., Berneman, Zwi N., Anguille, Sébastien
Publicado 2019

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15

por Van Acker, Heleen H., Van Acker, Zoë P., Versteven, Maarten, Ponsaerts, Peter, Pende, Daniela, Berneman, Zwi N., Anguille, Sébastien, Van Tendeloo, Viggo F., Smits, Evelien L.
Publicado 2019

Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation

por Capsomidis, Anna, Benthall, Gabriel, Van Acker, Heleen H., Fisher, Jonathan, Kramer, Anne M., Abeln, Zarah, Majani, Yvonne, Gileadi, Talia, Wallace, Rebecca, Gustafsson, Kenth, Flutter, Barry, Anderson, John
Publicado 2018

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

por Timmers, Marijke, Roex, Gils, Wang, Yuedi, Campillo-Davo, Diana, Van Tendeloo, Viggo F. I., Chu, Yiwei, Berneman, Zwi N., Luo, Feifei, Van Acker, Heleen H., Anguille, Sébastien
Publicado 2019

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity

por van Beek, Jasper J. P., Gorris, Mark A. J., Sköld, Annette E., Hatipoglu, Ibrahim, Van Acker, Heleen H., Smits, Evelien L., de Vries, I. Jolanda M., Bakdash, Ghaith
Publicado 2016

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

por van Ee, Thomas J., Van Acker, Heleen H., van Oorschot, Tom G., Van Tendeloo, Viggo F., Smits, Evelien L., Bakdash, Ghaith, Schreibelt, Gerty, de Vries, I. Jolanda M.
Publicado 2018

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells

por Van Acker, Heleen H., Beretta, Ottavio, Anguille, Sébastien, Caluwé, Lien De, Papagna, Angela, Van den Bergh, Johan M., Willemen, Yannick, Goossens, Herman, Berneman, Zwi N., Van Tendeloo, Viggo F., Smits, Evelien L., Foti, Maria, Lion, Eva
Publicado 2017

Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer

por Celus, Ward, Oliveira, Ana I., Rivis, Silvia, Van Acker, Heleen H., Landeloos, Ewout, Serneels, Jens, Cafarello, Sarah Trusso, Van Herck, Yannick, Mastrantonio, Roberta, Köhler, Arnaud, Garg, Abhishek D., Flamand, Véronique, Tamagnone, Luca, Marine, Jean-Christophe, Matteo, Mario Di, Costa, Bruno M., Bechter, Oliver, Mazzone, Massimiliano
Publicado 2022